1-235448220-CAAAAAAAAAAAAAA-CAAAAAAAAAAA

Variant summary

Our verdict is . The variant received 2 ACMG points: 2P and 0B. PM2

The NM_152490.5(B3GALNT2):​c.*1983_*1985delTTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00618 in 519,134 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000091 ( 0 hom., cov: 24)
Exomes 𝑓: 0.0071 ( 0 hom. )

Consequence

B3GALNT2
NM_152490.5 3_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0510

Publications

0 publications found
Variant links:
Genes affected
B3GALNT2 (HGNC:28596): (beta-1,3-N-acetylgalactosaminyltransferase 2) This gene encodes a member of the glycosyltransferase 31 family. The encoded protein synthesizes GalNAc:beta-1,3GlcNAc, a novel carbohydrate structure, on N- and O-glycans. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Mar 2013]
TBCE (HGNC:11582): (tubulin folding cofactor E) Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
TBCE Gene-Disease associations (from GenCC):
  • hypoparathyroidism-retardation-dysmorphism syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • encephalopathy, progressive, with amyotrophy and optic atrophy
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, PanelApp Australia, ClinGen, Ambry Genetics
  • autosomal recessive Kenny-Caffey syndrome
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_152490.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Variant has high frequency in the EAS (0.0082) population. However there is too low homozygotes in high coverage region: (expected more than 4, got 0).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152490.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GALNT2
NM_152490.5
MANE Select
c.*1983_*1985delTTT
3_prime_UTR
Exon 12 of 12NP_689703.1Q8NCR0-1
TBCE
NM_003193.5
MANE Select
c.1400-111_1400-109delAAA
intron
N/ANP_003184.1Q15813-1
TBCE
NM_001287801.2
c.1553-111_1553-109delAAA
intron
N/ANP_001274730.1Q15813-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GALNT2
ENST00000366600.8
TSL:1 MANE Select
c.*1983_*1985delTTT
3_prime_UTR
Exon 12 of 12ENSP00000355559.3Q8NCR0-1
TBCE
ENST00000642610.2
MANE Select
c.1400-111_1400-109delAAA
intron
N/AENSP00000494796.1Q15813-1
ENSG00000285053
ENST00000647186.1
c.1400-111_1400-109delAAA
intron
N/AENSP00000494775.1

Frequencies

GnomAD3 genomes
AF:
0.0000915
AC:
6
AN:
65580
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000192
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000806
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00706
AC:
3200
AN:
453554
Hom.:
0
AF XY:
0.00684
AC XY:
1681
AN XY:
245888
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00523
AC:
58
AN:
11098
American (AMR)
AF:
0.00600
AC:
142
AN:
23670
Ashkenazi Jewish (ASJ)
AF:
0.00860
AC:
129
AN:
15002
East Asian (EAS)
AF:
0.00913
AC:
250
AN:
27378
South Asian (SAS)
AF:
0.00218
AC:
112
AN:
51260
European-Finnish (FIN)
AF:
0.00910
AC:
261
AN:
28676
Middle Eastern (MID)
AF:
0.00377
AC:
11
AN:
2920
European-Non Finnish (NFE)
AF:
0.00763
AC:
2053
AN:
269230
Other (OTH)
AF:
0.00757
AC:
184
AN:
24320
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.259
Heterozygous variant carriers
0
384
769
1153
1538
1922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000915
AC:
6
AN:
65580
Hom.:
0
Cov.:
24
AF XY:
0.0000982
AC XY:
3
AN XY:
30556
show subpopulations
African (AFR)
AF:
0.000192
AC:
4
AN:
20884
American (AMR)
AF:
0.00
AC:
0
AN:
5664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1664
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1594
European-Finnish (FIN)
AF:
0.000806
AC:
2
AN:
2480
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
138
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
30296
Other (OTH)
AF:
0.00
AC:
0
AN:
860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
2

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.051
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.